Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
+0.58%
619.21
+3.56
+0.58%
615.65615.07619.70614.21
SX6P
Utilities
SX6P
Utilities
SX6P
-3.70%
530.86
-20.38
-3.70%
551.24548.70548.70530.09
SX8P
Technology
SX8P
Technology
SX8P
-1.74%
930.62
-16.46
-1.74%
947.08946.19946.19917.62
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-1.87%
456.05
-8.70
-1.87%
464.75463.99464.64453.17
SXDP
Health Care
SXDP
Health Care
SXDP
-0.35%
1,090.63
-3.82
-0.35%
1,094.451,093.531,102.341,089.23
SXEP
Energy
SXEP
Energy
SXEP
-0.14%
535.34
-0.73
-0.14%
536.07535.49537.10532.16
SXFP
Financials
SXFP
Financials
SXFP
-0.53%
890.23
-4.73
-0.53%
894.96895.33896.45886.07
SXKP
Communications
SXKP
Communications
SXKP
-1.11%
312.78
-3.52
-1.11%
316.30317.30317.88312.06
SXNP
Industrials
SXNP
Industrials
SXNP
-2.47%
1,095.60
-27.75
-2.47%
1,123.351,118.991,118.991,092.58
SXPP
Materials
SXPP
Materials
SXPP
-5.11%
818.07
-44.02
-5.11%
862.09841.63841.63810.46
RXRX:NASDAQ
Recursion Pharmaceuticals Inc
$2.93
-3.62%
(-0.11) 1D
$2.92
-0.34% (-0.0100)
After hours
Closed: May 15, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RXRX...
Open
$3.00
High
$3.05
Low
$2.92
Mkt. cap
1.55B
Avg. vol.
11.91M
Volume
17.43M
52-wk high
$7.18
52-wk low
$2.80
EPS
-$1.20
Beta
1.05
Shares outstanding
524.68M
No. of employees
600
News stories
From sources across the web
About Recursion Pharmaceuticals Inc
CEONajat Khan
Employees600
Founded2013
HeadquartersSalt Lake City, Utah, United States
SectorBiotechnology
Last report
May 6, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
-$0.22 / -$0.26
+14.44%beat
Revenue / Est. (USD)
6.47M / 15.78M
-58.98%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
19.22M
5.18M
35.54M
6.47M
Cost of goods sold
148.80M
135.75M
110.22M
100.39M
Cost of revenue
148.80M
135.75M
110.22M
100.39M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
46.65M
41.63M
42.17M
34.59M
Operating expense
46.65M
41.63M
42.17M
34.59M
Total operating expenses
195.45M
177.38M
152.39M
134.98M
Operating income
-176.23M
-172.20M
-116.85M
-128.50M
Other non operating income
-633.00K
5.24M
-6.03M
784.00K
EBT including unusual items
-171.90M
-162.25M
-108.10M
-122.11M
EBT excluding unusual items
-171.90M
-162.25M
-116.62M
-122.11M
Income tax expense
-
3.00K
20.00K
-4.60M
Effective tax rate
-
-
-0.02%
3.77%
Other operating expenses
-
-
-
-
Net income
-171.90M
-162.25M
-108.12M
-117.50M
Net profit margin
-894.23%
-3,135.32%
-304.24%
-1,815.57%
Earnings per share
-0.41
-0.36
-0.21
-0.22
Interest and investment income
5.44M
5.54M
6.26M
5.96M
Interest expense
-480.00K
-833.00K
-
-350.00K
Net interest expenses
4.96M
4.71M
6.26M
5.61M
Depreciation and amortization charges
-
-
-
-
EBITDA
-152.38M
-151.16M
-97.37M
-108.83M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more